For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Atai Therapeutics Inc.

USPTO Granted Patents = 12

Forward Citations = 11

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Glenn Short (6 out of 12 patents)

Robert B Perni (5 out of 55 patents)

Tanweer A Khan (5 out of 17 patents)

4. Majed Fawaz (2 out of 10 patents)

5. Jacqueline L Salm (2 out of 8 patents)

6. Christopher G Witowski (2 out of 8 patents)

7. Srinivas G Rao (2 out of 20 patents)

8. Holger Weis (1 out of 5 patents)

9. Emeline Maillet (1 out of 7 patents)

10. Prahlad Krishnan (1 out of 2 patents)

11. Glen Short (1 out of 1 patent)

12. Santnu Patel (1 out of 1 patent)

13. Prerak Patel (1 out of 1 patent)

14. Nicholas Morra (1 out of 3 patents)

15. Benjamin Robert Difrancesco (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12472163 - Compositions of matter and pharmaceutical compositions (2025-11-18),

2. 12396982 - Compositions of matter and pharmaceutical compositions (2025-08-26),

3. 12378194 - N, n-dimethyltryptamine salts and crystalline salt forms (2025-08-05),

4. 12351537 - Dimethoxyphenylalkylamine activators of serotonin receptors (2025-07-08),

5. 12344570 - Aminotetraline activators of serotonin receptors (2025-07-01),

6. 12343319 - Compositions and methods for treatment of diseases and disorders (2025-07-01),

7. 12128027 - N—N-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereof (2024-10-29),

8. 12097332 - Systems, devices, and methods for generating and manipulating objects in a virtual reality or multi-sensory environment to maintain a positive state of a user (2024-09-24),

9. 12065405 - Prodrugs and conjugates of dimethyltryptamine (2024-08-20),

10. 12016866 - Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids (2024-06-25),

11. 12012381 - Dimethyltryptamine analogues as nitric oxide delivery drugs (2024-06-18),

12. 11926574 - Dimethoxyphenylalkylamine activators of serotonin receptors (2024-03-12),

Atai Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for mental health disorders. Their unique approach combines cutting-edge research in the fields of neuroscience, pharmacology, and psychology to advance new treatment options for patients suffering from conditions such as depression, anxiety, and PTSD.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#541 in New York, NY

#1,385 in New York

#24,828 in US

#46,735 in the World

New York, NY, United States of America

Atai Therapeutics Inc.

Forward Citations = 11

19 inventors:

Glenn Short (6 out of 12 patents)

Robert B Perni (5 out of 55 patents)

Tanweer A Khan (5 out of 17 patents)

4. Majed Fawaz (2 out of 10 patents)

5. Jacqueline L Salm (2 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…